Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006

J Czernin, M Allen-Auerbach… - Journal of Nuclear …, 2007 - Soc Nuclear Med
PET/CT with 18 F-FDG is increasingly being used for staging, restaging, and treatment
monitoring for cancer patients. CT is still frequently used only for attenuation correction and …

Utilization of positron emission tomography in the management of patients with sarcoma

MR Benz, N Tchekmedyian, FC Eilber… - Current opinion in …, 2009 - journals.lww.com
Utilization of positron emission tomography in the managemen... : Current Opinion in Oncology
Utilization of positron emission tomography in the management of patients with sarcoma …

FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases

M Charest, M Hickeson, R Lisbona… - European journal of …, 2009 - Springer
Purpose The aims of this study are to evaluate the sensitivity of FDG PET/CT for detection of
soft tissue and osseous sarcomas on the basis of FDG avidity. Methods We retrospectively …

Pediatric Bone Sarcoma: Diagnostic Performance of 18F-FDG PET/CT Versus Conventional Imaging for Initial Staging and Follow-Up

N Quartuccio, J Fox, D Kuk, LH Wexler… - American Journal of …, 2015 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study was to compare the diagnostic performance of 18F-
FDG PET/CT and conventional imaging for staging and follow-up of pediatric osteosarcoma …

Staging of bone and soft-tissue sarcomas

RJ Steffner, ES Jang - JAAOS-Journal of the American Academy …, 2018 - journals.lww.com
The purpose of staging in orthopaedic oncology is to provide a framework for classifying
tumors based on their risk of local recurrence and distant metastasis to guide treatment …

Role of 18F-FDG PET/CT in management of high-grade salivary gland malignancies

HS Jeong, MK Chung, YI Son, JY Choi… - Journal of Nuclear …, 2007 - Soc Nuclear Med
The role of 18F-FDG PET/CT for planning the treatment of high-grade salivary gland
malignancies was investigated and was compared with that with using contrast-enhanced …

ACR appropriateness criteria follow-up of malignant or aggressive musculoskeletal tumors

CC Roberts, MJ Kransdorf, FD Beaman… - Journal of the American …, 2016 - Elsevier
Appropriate imaging modalities for the follow-up of malignant or aggressive musculoskeletal
tumors include radiography, MRI, CT, 18 F-2-fluoro-2-deoxy-D-glucose PET/CT, 99m Tc …

Applications of PET‐MRI in musculoskeletal disease

F Kogan, SM Broski, D Yoon… - Journal of Magnetic …, 2018 - Wiley Online Library
New integrated PET‐MRI systems potentially provide a complete imaging modality for
diagnosis and evaluation of musculoskeletal disease. MRI is able to provide excellent high …

Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: a meta-analysis of 23 studies

T Huang, F Li, Z Yan, Y Ma, F Xiong, X Cai, Q Zhang… - Medicine, 2018 - journals.lww.com
Background: To investigate the value of positron emission tomography (PET) and
PET/computed tomography (CT) using fluorine-18-fluorodeoxyglucose (18 F-FDG) in the …

Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma

A Raciborska, K Bilska, K Drabko, E Michalak… - Clinical and …, 2016 - Springer
Background Response to chemotherapy is a prognostic factor in patients with Ewing
sarcoma (ES); the role of FDG PET to predict response in these patients has not been …